Qube Research & Technologies (QRT)
TBPH icon

Qube Research & Technologies (QRT)’s Theravance Biopharma TBPH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.7M Sell
289,473
-184,025
-39% -$3.26M 0.01% 1688
2025
Q4 		$8.86M Buy
473,498
+262,450
+124% +$4.35M 0.01% 1425
2025
Q3 		$3.08M Buy
211,048
+5,768
+3% +$72.9K ﹤0.01% 2010
2025
Q2 		$2.26M Buy
205,280
+91,341
+80% +$888K ﹤0.01% 2152
2025
Q1 		$1.02M Buy
+113,939
New +$1.06M ﹤0.01% 2253
2020
Q4 		– Sell
-17,094
Closed -$253K – 2190
2020
Q3 		$253K Buy
17,094
+3,971
+30% +$74.4K ﹤0.01% 1312
2020
Q2 		$275K Buy
+13,123
New +$337K ﹤0.01% 1339

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.1B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return